06/06/2026
A significant milestone in our journey towards strengthening global regulatory excellence.
Akums has received the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its API, Cefpodoxime Proxetil. This certification confirms compliance with the stringent requirements of the European Pharmacopoeia and reinforces our commitment to quality, compliance, and scientific excellence.
As global pharmaceutical markets continue to demand highly compliant and traceable APIs, regulatory recognitions such as CEP play a vital role in enabling access to regulated markets and strengthening supply chain confidence.
Read the Article to Know more - https://www.expresspharma.in/akums-receives-edqm-cep-approval-for-cefpodoxime-proxetil-api/